Literature DB >> 24292247

Epidemiological investigation of equine piroplasmosis in China by enzyme-linked immunosorbent assays.

Ming Wang1, Wei Guo, Ikuo Igarashi, Xuenan Xuan, Xiaojun Wang, Wenhua Xiang, Honglin Jia.   

Abstract

The objective of this study is to investigate the seroprevalence of equine piroplasmosis in China. A total of 1990 sera were collected from clinically healthy horses in various districts located in ten different provinces of China and examined by using indirect enzyme-linked immunosorbent assays (ELISAs) with recombinant Theileria equi (T. equi) merozoite antigen 2 (rEMA-2) and Babesia caballi (B. caballi) 48-kDa rhoptry protein (rBc48), respectively. The results showed that 1,018 (51.16%) and 229 (11.51%) samples were positive for B. caballi and T. equi infection, respectively. The number of samples with mixed infection was 152 (7.64%). These results indicated that equine piroplasmosis was widespread in China.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292247      PMCID: PMC4064140          DOI: 10.1292/jvms.13-0477

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


Equine piroplasmosis is a tick-borne disease of horses, donkeys, mules and zebra. This disease is caused by two kinds of hemoprotozoan parasites, named as Babesia caballi (B. caballi) and Theileria equi (T. equi), both of which are transmitted by species of Ixodid ticks [5]. Clinically, the acute phase of the disease is characterized by fever, anorexia, weight loss, tachypnea and congestion of mucous membranes, but chronic infection usually presents unconspicuous clinical symptoms. Persistently-infected horses that recover from the acute infection usually carry the parasites for lifelong and serve as the reservoir hosts for transmission to other susceptible animals [21]. There are no vaccines available for this disease [12]. The control measures of equine piroplasmosis require effective diagnostic approaches that can detect carrier or chronically infected animals. Equine piroplasmosis has a worldwide distribution. In recent years, many surveillance studies of equine piroplasmosis have been reported in many countries all over the world, such as Korea, Mongolia, Venezuelan, Tunisia, Sudan, Italy, Hungary, Saudi Arabia, Mexico and Texas of U.S.A. [1, 3, 7, 10, 13,14,15,16,17,18]. In China, B. caballi and T. equi were documented in Heilongjiang Province as early as 1943 [25]. Although both B. caballi and T. equi infections have been identified in China, a comprehensive survey of the infections has never been conducted [4, 22, 24]. Equine piroplasmosis causes serious health effects to horses, especially with respect to agricultural production including low working capacity, high cost of the control measures and impact on the transport of goods and international trade [12]. Therefore, there is an urgent need to determine the prevalence of the disease in China to facilitate the control of the infection. The immunodominant merozoite surface protein of T. equi (EMA-2) is expressed throughout life cycle of the parasite, in both vector tick stage and in mammalian host stage [20]. The 48-kDa merozoite rhoptry protein of B. caballi (Bc48) is recognized earliest by the host immune system and throughout infection [2]. Indirect enzyme-linked immunosorbent assay (ELISAs) using recombinant EMA-2 and Bc48 (rEMA-2 and rBc48) is highly sensitive and specific for detecting antibodies in infected horses and widely used in serological surveillance of equine piroplasmosis [6, 11, 12, 19]. The rEMA-2 and rBc48 were expressed in Escherichia coli(E. coli) and purified as Glutathione S-transferase (GST) fusion proteins as described previously. The recombinant GST was also expressed and purified as a control [9]. The ELISA was performed as described previously [23]. Briefly, 96-well plates were coated overnight at 4 °C with 2 µg/ml purified recombinant proteins in coating buffer (carbonate-bicarbonate buffer, PH 9.6), respectively. The plates were washed once with washing buffer (phosphate buffer saline with tween-20) and then blocked with blocking buffer (3% skimmed milk dissolving in phosphate buffer saline) for 2 hr at 37°C. After washing once with the washing buffer, 100 µl of horse sera diluted in blocking buffer were added into the wells and incubated at 37°C for 1 hr. The plates were then washed six times with washing buffer, subsequently filled with HRP conjugated goat anti-horse IgG (Jackson Immunoresearch Laboratories, West Grove, PA, U.S.A.) diluted in the blocking buffer and incubated at 37 °C for 1 hr. The plates were then washed six times with washing buffer, and 2,2’-Azinobis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS) was used as a substrate. After incubation at room temperature for 30 min, the absorbance at 405 nm was measured using a microplate reader (Benchmark Plus, BioRad, Hercules, CA, U.S.A.) The ELISA results for each sample were calculated by substracting the mean absorbance values of rGST from the mean absorbance values of rEMA-2 or rBc48. The samples were considered positive for T. equi infection, if the calculated absorbance value with rEMA-2 was equal to or greater than 0.1 [8]. The samples with OD value more than 0.2 were considered as positive for B. cabali infection in the ELISA with rBc48 [24]. In this study, a total of 1990 serum samples were collected from ten different provinces or areas of China, including Hebei, Beijing, Shaanxi, Guangdong, Xinjiang, Ningxia, Yunnan, Guizhou, Gansu and Jiangsu, and some of them are vital localities for the horse industry in China. The positive rates in the ELISAs using the two antigens are shown in Table 1, and the distribution of OD values is shown in Fig. 1. Totally, 1,018 (51.16%) and 229 (11.51%) equine samples were positive for B. caballi and T. equi infection, respectively. Mixed infections were detected in 152 (7.64%) serum samples. Although there were no samples collected in northeast of China in this study, another study conducted in 2003 reported that, out of 111 equine samples, 38 (34%) and 36 (32%) samples were positive for T. equi and B. caballi infection, respectively [22]. These results indicated that equine piroplasmosis is widespread in China, and therefore, the impact on the horse industry caused by this disease should be considered. The seroprevalence of B. caballi and T. equi infection in different locations is shown in Fig. 2. The highest prevalence of B. caballi was found in Ningxia province (77.61%), and the lowest infection rate was noted in the Guizhou province (20%). Likewise, the highest infection rate of T. equi was found in Yunnan province (37.58%), and the lowest prevalence was noted in Shaanxi province (1.04%). Notably, the seroprevalence of B. caballi was significant higher than that of T. equi in nine provinces, except for Hebei. Differences of the positive rate might be caused by the difference in distribution of tick vectors or the use of horses.
Table 1.

Prevalence of equine piroplasmosis in ten provinces or areas of China

Provinces or areasNo. of samplesexaminedNo. of B. caballi-positivesamplesNo. of T. equi-positivesamplesMixed infection
Hebei5315 (28.3%)16 (30.19%)2 (3.77%)
Guangdong26684 (31.58%)23 (8.65%)23 (8.65%)
Shaanxi19285 (44.27%)2 (1.04%)2 (1.04%)
Xinjiang350271 (77.43%)34 (9.71%)30 (8.57%)
Jiangsu22780 (35.24%)9 (3.96%)4 (1.76%)
Yunnan298200 (67.15%)112 (37.58%)92 (30.87%)
Beijing14951 (34.23%)3 (2.01%)2 (1.34%)
Guizhou12024 (20%)9 (7.5%)3 (2.5%)
Ningxia201156 (77.61%)8 (3.98%)3 (1.49%)
Gansu13452 (38.81%)13 (9.7%)4 (2.99%)
Total19901018 (51.16%)229 (11.51%)152 (7.64%)
Fig. 1.

A, Distribution of ELISA results using rBc48 represented by OD value. The ELISA cutoff value was determined as 0.2. B, Distribution of ELISA results using rEMA-2 represented by OD value. The ELISA cutoff value was determined as 0.1.

Fig. 2.

The seroprevalence of B. caballi and T. equi infections and sampling locations.

A, Distribution of ELISA results using rBc48 represented by OD value. The ELISA cutoff value was determined as 0.2. B, Distribution of ELISA results using rEMA-2 represented by OD value. The ELISA cutoff value was determined as 0.1. The seroprevalence of B. caballi and T. equi infections and sampling locations. In 2002, a surveillance study of equine piroplasmosis in Xinjiang province reported that, out of the 70 samples collected from three farms in Xinjiang, 28 (40.0%) and 17 (24.3%) were positive for T. equi infection and B. caballi infection respectively [24]. Out of all the 350 sera, 34 (9.71%) samples were positive for T. equi, while 271 (77.43%) were positive for B. caballi in the present study. The positive rate of B. caballi infection was predominant over T. equi. This difference might be caused by the differences of sampling time and sample number. The dominant positive rate of B. caballi infection was also reported in a study conducted in Mongolia (adjacent to Xinjiang province), in which the positive rate for T. equi and B. caballi infection out of 250 samples was 49 (19.6%) and 129 (51.6%), respectively. Serological surveillance of B. caballi and T. equi infections has been conducted in many countries. However, extensive survey of the prevalence about this disease in China has never been performed. There were few reports, and most of them focused on the northern China, rather than southern China. Our data demonstrate the successful applications of ELISAs with rBc48 and rEMA-2 as antigens for investigating the epidemiology of equine piroplasmosis caused by B. caballi and T. equi infections in horses in China. To our knowledge, this study is the first comprehensive survey for equine piroplasmosis in China. Our data may be regarded as important information that would contribute to establish prevention and control measures against equine piroplasmosis in China.
  24 in total

1.  Diagnosis of equine piroplasmosis in Brazil by serodiagnostic methods with recombinant antigens.

Authors:  X Xuan; A Nagai; B Battsetseg; S Fukumoto; L H Makala; N Inoue; I Igarashi; T Mikami; K Fujisaki
Journal:  J Vet Med Sci       Date:  2001-10       Impact factor: 1.267

2.  High-level expression and purification of a truncated merozoite antigen-2 of Babesia equi in Escherichia coli and its potential for immunodiagnosis.

Authors:  Xiaohong Huang; Xuenan Xuan; Naoaki Yokoyama; Longshan Xu; Hiroshi Suzuki; Chihiro Sugimoto; Hideyuki Nagasawa; Kozo Fujisaki; Ikuo Igarashi
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 3.  Equine piroplasmosis: a review.

Authors:  D T de Waal
Journal:  Br Vet J       Date:  1992 Jan-Feb

4.  Babesiosis in China.

Authors:  H Yin; W Lu; J Luo
Journal:  Trop Anim Health Prod       Date:  1997-11       Impact factor: 1.559

5.  Prevalence of tick borne pathogens in horses from Italy.

Authors:  Fulvio Laus; Fabrizia Veronesi; Fabrizio Passamonti; Emanuele Paggi; Matteo Cerquetella; Doreene Hyatt; Beniamino Tesei; Daniela Piergili Fioretti
Journal:  J Vet Med Sci       Date:  2013-01-18       Impact factor: 1.267

6.  Detection of Theileria equi and Babesia caballi infections in Venezuelan horses using Competitive-Inhibition ELISA and PCR.

Authors:  Romel Rosales; Ariadna Rangel-Rivas; América Escalona; Luis Segundo Jordan; Mary Isabel Gonzatti; Pedro Maria Aso; Trina Perrone; Adriana Silva-Iturriza; Alfredo Mijares
Journal:  Vet Parasitol       Date:  2013-03-05       Impact factor: 2.738

7.  Diagnosis of equine piroplasmosis in Xinjiang province of China by the enzyme-linked immunosorbent assays using recombinant antigens.

Authors:  Xuenan Xuan; Bayin Chahan; Xiaohong Huang; Naoaki Yokoyama; Levi Hakwale Makala; Ikuo Igarashi; Kozo Fujisaki; Soich Maruyama; Takeo Sakai; Takeshi Mikami
Journal:  Vet Parasitol       Date:  2002-09-10       Impact factor: 2.738

8.  Expression of equi merozoite antigen 2 during development of Babesia equi in the midgut and salivary gland of the vector tick Boophilus microplus.

Authors:  Massaro W Ueti; Guy H Palmer; Lowell S Kappmeyer; Glen A Scoles; Donald P Knowles
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Demonstration of the humoral immune response of horses to Babesia caballi by western blotting.

Authors:  R Böse; K Daemen
Journal:  Int J Parasitol       Date:  1992-08       Impact factor: 3.981

10.  Seroepidemiologic studies on Babesia equi and Babesia caballi infections in horses in Jilin province of China.

Authors:  Yingtian Xu; Shoufa Zhang; Xiaohong Huang; Chahan Bayin; Xuenan Xuan; Ikuo Igarashi; Kozo Fujisaki; Hidenori Kabeya; Soichi Maruyama; Takeshi Mikami
Journal:  J Vet Med Sci       Date:  2003-09       Impact factor: 1.267

View more
  5 in total

1.  Seroprevalence of Theileria equi and Babesia caballi in horses in Spain.

Authors:  Maria Guadalupe Montes Cortés; José Luis Fernández-García; Miguel Ángel Habela Martínez-Estéllez
Journal:  Parasite       Date:  2017-05-12       Impact factor: 3.000

Review 2.  A Review on Equine Piroplasmosis: Epidemiology, Vector Ecology, Risk Factors, Host Immunity, Diagnosis and Control.

Authors:  ThankGod E Onyiche; Keisuke Suganuma; Ikuo Igarashi; Naoaki Yokoyama; Xuenan Xuan; Oriel Thekisoe
Journal:  Int J Environ Res Public Health       Date:  2019-05-16       Impact factor: 3.390

3.  First report of genetic diversity and risk factor analysis of equine piroplasm infection in equids in Jilin, China.

Authors:  Shaowei Zhao; Hao Wang; Shuang Zhang; Suzhu Xie; Hang Li; Xuancheng Zhang; Lijun Jia
Journal:  Parasit Vectors       Date:  2020-09-09       Impact factor: 3.876

4.  Development of a Test Card Based on Colloidal Gold Immunochromatographic Strips for Rapid Detection of Antibodies against Theileria equi and Babesia caballi.

Authors:  Guangpu Yang; Kewei Chen; Wei Guo; Zhe Hu; Ting Qi; Diqiu Liu; Yaoxin Wang; Cheng Du; Xiaojun Wang
Journal:  Microbiol Spectr       Date:  2022-02-23

Review 5.  Twenty Years of Equine Piroplasmosis Research: Global Distribution, Molecular Diagnosis, and Phylogeny.

Authors:  Sharon Tirosh-Levy; Yuval Gottlieb; Lindsay M Fry; Donald P Knowles; Amir Steinman
Journal:  Pathogens       Date:  2020-11-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.